Delivery Order SPE2DB22D1106-SPE2DB25FDHL7
Award Date
10/17/24
Potential Completion Date
10/18/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,187.62 firm fixed-price delivery order is for the supply of dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This award is part of AmerisourceBergen's larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,266.22 firm fixed-price delivery order is for the supply of dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,855.89 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 19, 2024 and was awarded on September 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,071.13 firm fixed-price delivery order is for the supply of 4566405164 Dapagliflozin 10 mg tablets, a medication used to manage diabetes. The contract has a ceiling value of $4,071.13 and a completion date of November 13, 2024. This delivery order is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,471.44 firm fixed-price delivery order is for the supply of Dapagliflozin 5 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024.
This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $16,818.10 and is a Firm Fixed Price Delivery Order that runs through September 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dapagliflozin 10 mg tablets, which are used to treat type 2 diabetes. The contract has a ceiling value of $13,655.93 and a completion date of July 12, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,777.55, is for the delivery of dapagliflozin 10 mg tablets, a medication used to manage diabetes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,726.16 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used to manage diabetes. The contract has an ultimate completion date of September 26, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,682.04 firm fixed-price delivery order is for the supply of dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 20, 2024 and is not designated as a set-aside.
AmerisourceBergen holds two significant Indefinite Delivery Contracts...